BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis

Thomas C. Roberts, Usue Etxaniz, Alessandra Dall'agnese, Shwu Yuan Wu, Cheng Ming Chiang, Paul E. Brennan, Matthew J.A. Wood, Pier Lorenzo Puri

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Myogenic differentiation proceeds through a highly coordinated cascade of gene activation that necessitates epigenomic changes in chromatin structure. Using a screen of small molecule epigenetic probes we identified three compounds which inhibited myogenic differentiation in C2C12 myoblasts; (+)-JQ1, PFI-1, and Bromosporine. These molecules target Bromodomain and Extra Terminal domain (BET) proteins, which are epigenetic readers of acetylated histone lysine tail residues. BETi-mediated anti-myogenic effects were also observed in a model of MYOD1-mediated myogenic conversion of human fibroblasts, and in primary mouse and human myoblasts. All three BET proteins BRD2, BRD3 and BRD4 exhibited distinct and dynamic patterns of protein expression over the course of differentiation without concomitant changes in mRNA levels, suggesting that BET proteins are regulated at the post-transcriptional level. Specific BET protein knockdown by RNA interference revealed that BRD4 was required for myogenic differentiation, whereas BRD3 down-regulation resulted in enhanced myogenic differentiation. ChIP experiments revealed a preferential binding of BRD4 to the Myog promoter during C2C12 myoblast differentiation, co-incident with increased levels of H3K27 acetylation. These results have identified an essential role for BET proteins in the regulation of skeletal myogenesis, and assign distinct functions to BRD3 and BRD4.

Original languageEnglish (US)
Article number6153
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Muscle Development
Myoblasts
Epigenomics
Acetylation
RNA Interference
Histones
Transcriptional Activation
Lysine
Chromatin
Tail
Down-Regulation
Fibroblasts
Protein Domains
Messenger RNA
Proteins

ASJC Scopus subject areas

  • General

Cite this

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis. / Roberts, Thomas C.; Etxaniz, Usue; Dall'agnese, Alessandra; Wu, Shwu Yuan; Chiang, Cheng Ming; Brennan, Paul E.; Wood, Matthew J.A.; Puri, Pier Lorenzo.

In: Scientific Reports, Vol. 7, No. 1, 6153, 01.12.2017.

Research output: Contribution to journalArticle

Roberts, TC, Etxaniz, U, Dall'agnese, A, Wu, SY, Chiang, CM, Brennan, PE, Wood, MJA & Puri, PL 2017, 'BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis', Scientific Reports, vol. 7, no. 1, 6153. https://doi.org/10.1038/s41598-017-06483-7
Roberts, Thomas C. ; Etxaniz, Usue ; Dall'agnese, Alessandra ; Wu, Shwu Yuan ; Chiang, Cheng Ming ; Brennan, Paul E. ; Wood, Matthew J.A. ; Puri, Pier Lorenzo. / BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{1dc809e1fce949968b1aee634dd1e8c4,
title = "BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis",
abstract = "Myogenic differentiation proceeds through a highly coordinated cascade of gene activation that necessitates epigenomic changes in chromatin structure. Using a screen of small molecule epigenetic probes we identified three compounds which inhibited myogenic differentiation in C2C12 myoblasts; (+)-JQ1, PFI-1, and Bromosporine. These molecules target Bromodomain and Extra Terminal domain (BET) proteins, which are epigenetic readers of acetylated histone lysine tail residues. BETi-mediated anti-myogenic effects were also observed in a model of MYOD1-mediated myogenic conversion of human fibroblasts, and in primary mouse and human myoblasts. All three BET proteins BRD2, BRD3 and BRD4 exhibited distinct and dynamic patterns of protein expression over the course of differentiation without concomitant changes in mRNA levels, suggesting that BET proteins are regulated at the post-transcriptional level. Specific BET protein knockdown by RNA interference revealed that BRD4 was required for myogenic differentiation, whereas BRD3 down-regulation resulted in enhanced myogenic differentiation. ChIP experiments revealed a preferential binding of BRD4 to the Myog promoter during C2C12 myoblast differentiation, co-incident with increased levels of H3K27 acetylation. These results have identified an essential role for BET proteins in the regulation of skeletal myogenesis, and assign distinct functions to BRD3 and BRD4.",
author = "Roberts, {Thomas C.} and Usue Etxaniz and Alessandra Dall'agnese and Wu, {Shwu Yuan} and Chiang, {Cheng Ming} and Brennan, {Paul E.} and Wood, {Matthew J.A.} and Puri, {Pier Lorenzo}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-06483-7",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis

AU - Roberts, Thomas C.

AU - Etxaniz, Usue

AU - Dall'agnese, Alessandra

AU - Wu, Shwu Yuan

AU - Chiang, Cheng Ming

AU - Brennan, Paul E.

AU - Wood, Matthew J.A.

AU - Puri, Pier Lorenzo

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Myogenic differentiation proceeds through a highly coordinated cascade of gene activation that necessitates epigenomic changes in chromatin structure. Using a screen of small molecule epigenetic probes we identified three compounds which inhibited myogenic differentiation in C2C12 myoblasts; (+)-JQ1, PFI-1, and Bromosporine. These molecules target Bromodomain and Extra Terminal domain (BET) proteins, which are epigenetic readers of acetylated histone lysine tail residues. BETi-mediated anti-myogenic effects were also observed in a model of MYOD1-mediated myogenic conversion of human fibroblasts, and in primary mouse and human myoblasts. All three BET proteins BRD2, BRD3 and BRD4 exhibited distinct and dynamic patterns of protein expression over the course of differentiation without concomitant changes in mRNA levels, suggesting that BET proteins are regulated at the post-transcriptional level. Specific BET protein knockdown by RNA interference revealed that BRD4 was required for myogenic differentiation, whereas BRD3 down-regulation resulted in enhanced myogenic differentiation. ChIP experiments revealed a preferential binding of BRD4 to the Myog promoter during C2C12 myoblast differentiation, co-incident with increased levels of H3K27 acetylation. These results have identified an essential role for BET proteins in the regulation of skeletal myogenesis, and assign distinct functions to BRD3 and BRD4.

AB - Myogenic differentiation proceeds through a highly coordinated cascade of gene activation that necessitates epigenomic changes in chromatin structure. Using a screen of small molecule epigenetic probes we identified three compounds which inhibited myogenic differentiation in C2C12 myoblasts; (+)-JQ1, PFI-1, and Bromosporine. These molecules target Bromodomain and Extra Terminal domain (BET) proteins, which are epigenetic readers of acetylated histone lysine tail residues. BETi-mediated anti-myogenic effects were also observed in a model of MYOD1-mediated myogenic conversion of human fibroblasts, and in primary mouse and human myoblasts. All three BET proteins BRD2, BRD3 and BRD4 exhibited distinct and dynamic patterns of protein expression over the course of differentiation without concomitant changes in mRNA levels, suggesting that BET proteins are regulated at the post-transcriptional level. Specific BET protein knockdown by RNA interference revealed that BRD4 was required for myogenic differentiation, whereas BRD3 down-regulation resulted in enhanced myogenic differentiation. ChIP experiments revealed a preferential binding of BRD4 to the Myog promoter during C2C12 myoblast differentiation, co-incident with increased levels of H3K27 acetylation. These results have identified an essential role for BET proteins in the regulation of skeletal myogenesis, and assign distinct functions to BRD3 and BRD4.

UR - http://www.scopus.com/inward/record.url?scp=85025459207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025459207&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-06483-7

DO - 10.1038/s41598-017-06483-7

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6153

ER -